comparison plasma exchang plasma infus treatment thrombot thrombocytopen purpura canadian apheresi studi group background thrombot thrombocytopen purpura uncommon diseas high mortal rate current treatment caus syndrom optim treatment unknown plasma exchang plasma infus use treatment clear superior report prospect trial plasma exchang plasma infus treatment thrombot thrombocytopen purpura method patient thrombot thrombocytopen purpura plasma exchang infus fresh-frozen plasma first day entri trial total volum plasma patient plasma exchang time patient plasma infus patient aspirin dipyridamol outcom group end first treatment cycl day month result end first treatment cycl patient plasma exchang rate respons increas platelet count patient plasma infus patient plasma exchang patient plasma infus month outcom plasma-exchang group superior respons patient wherea patient plasma-infus group eleven patient plasma-exchang group patient plasma-infus group overal mortal percent conclus plasma exchang effect plasma infus treatment thrombot thrombocytopen purpura 